Back to top
more

Owens & Minor (OMI)

(Delayed Data from NYSE)

$18.62 USD

18.62
699,530

-0.49 (-2.56%)

Updated May 17, 2024 04:00 PM ET

After-Market: $18.62 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (145 out of 249)

Industry: Medical - Products

Better trading starts here.

Zacks News

Top Ranked Growth Stocks to Buy for August 5th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 5th.

Owens & Minor (OMI) Tops Q2 Earnings Estimates

Owens & Minor (OMI) delivered earnings and revenue surprises of 5.26% and -4.77%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Kinjel Shah headshot

4 Price-to-Book Value Picks to Buy in August

P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.

Top Ranked Growth Stocks to Buy for August 4th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, August 4th

Owens & Minor (OMI) Earnings Expected to Grow: Should You Buy?

Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Surging Earnings Estimates Signal Upside for Owens & Minor (OMI) Stock

Owens & Minor (OMI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Owens & Minor, Inc. (OMI) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Owens & Minor, Inc. (OMI).

Top Ranked Growth Stocks to Buy for July 24th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 24th

Is Owens & Minor (OMI) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Owens & Minor (OMI) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Amedisys (AMED) Broadens Hospice Base With AseraCare Buyout

Amedisys (AMED) expects AseraCare business to add greater scale to its existing nationwide network.

Medtronic Alters ECMO Therapy on New FDA Rules for Coronavirus

Medtronic (MDT), in response to the FDA's new guidance due to the coronavirus-led health emergency, has made temporary alterations to its cardiopulmonary product indications for use in ECMO therapy.

Tandem Diabetes Rides on Control-IQ Amid Coronavirus Crisis

Strong domestic pump sales and international expansion boosts sales of Tandem Diabetes (TNDM).

Here's Why You Should Hold on to Tandem Diabetes Stock for Now

Investors continue to be optimistic about Tandem Diabetes (TNDM) on robust pump sales and international growth.

QIAGEN Sales Grow on Coronavirus Solutions Ahead of Selloff

QIAGEN (QGEN) ramps up production capacity of solutions currently being used for testing purposes.

Thermo Fisher (TMO) Partners With CSL to Expand Pharma Arm

Thermo Fisher (TMO), through its alliance with CSL, expands Pharma Services arm to meet the rising demand for biologic therapies.

Quest Diagnostics' Self-Collection Coronavirus Kit Gets EUA

This kit by Quest Diagnostics (DGX) is suitable for use in children supervised by an adult.

LabCorp Partners With Medable to Expand Technology Ecosystem

LabCorp (LH) expands technology ecosystem to accelerate the adoption of decentralized clinical trials by collaborating with Medable.

Zimmer Biomet Faces Procedure Delays, Long-Term Potential Solid

Zimmer Biomet (ZBH) believes COVID-19 to continue to have a significant unfavorable impact on its sales in the near term.

Here's Why You Should Hold on to Chemed (CHE) Stock for Now

Investors continue to be optimistic about Chemed (CHE) on robust segmental growth.

Teleflex (TFX) Rides on UroLift Sales Amid Coronavirus Mayhem

NeoTract, the acquired business of Teleflex (TFX), continues to perform impressively.

IDEXX Sees Higher Clinical Visits Despite Coronavirus Crisis

IDEXX (IDXX) notes a significant improvement in U.S. clinical visit trends across major regions.

Henry Schein Sales Drop on Coronavirus Woes, Costs Rise

Henry Schein (HSIC) registers dismal performance within Dental business on suspension of non-emergency procedures in response to the pandemic.

Medtronic Gets FDA Nod for Guardian CGM's Android Version

Medtronic (MDT) expands reach to diabetic patients by introducing the Guardian Connect CGM system's Android version post its FDA clearance.

Should Value Investors Buy Owens & Minor (OMI) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.